Allergan Aesthetics, a division of AbbVie (NYSE: ABBV), is extending an invitation to consumers to participate in future campaigns featuring their flagship brands, such as BOTOX® Cosmetic, the JUVÉDERM® Collection of Fillers, and Allē, their loyalty rewards program. Starting today, individuals, whether current patients or prospective ones, can apply for the opportunity to be showcased in upcoming brand initiatives. The initial open casting call for BOTOX® Cosmetic drew approximately 20,000 entries, culminating in a compelling campaign highlighting a diverse array of patients sharing their genuine stories and motivations behind seeking aesthetic treatments.
Jasson Gilmore, Senior Vice President of U.S. Aesthetics, emphasized the continuation of their commitment to spotlighting natural-looking outcomes achieved by real patients and their providers across their brands. He noted the profound impact of witnessing relatable individuals sharing their aesthetic journeys and expressed the company’s dedication to amplifying authentic patient voices while fostering greater diversity within the industry.
Allergan Aesthetics has partnered with Cosmetic Executive Women (CEW), Black Beauty Roster, Latinas in Beauty, and The Black Beauty Club to promote the open casting call among their members, providing a platform for real patients to share their personal experiences.
The forthcoming campaigns will feature various content formats, including personal testimonials, before-and-after treatment visuals, behind-the-scenes footage, self-recorded treatment diaries, and YouTube and social media series showcasing transformations.
The open casting call will be open until June 4, 2024, with applications accepted at www.alle.com/castingcall. The final selections for each brand’s campaign will be announced later this year.
Important Safety Information:
BOTOX® Cosmetic is indicated for the temporary improvement of moderate to severe forehead lines, crow’s feet lines, and frown lines between the eyebrows in adults. It may cause serious side effects, including problems with swallowing, speaking, or breathing, and spread of toxin effects. Patients should seek immediate medical attention if they experience such issues after treatment.
JUVÉDERM® Injectable Gel Fillers are intended for various facial areas to correct age-related volume loss, enhance facial contours, and reduce the appearance of wrinkles and folds. These products carry risks, including the potential for unintentional injection into blood vessels, which can lead to serious complications.
Patients should consult with their healthcare providers to determine suitability for these treatments and to understand potential risks and benefits.
To report side effects or seek further information, individuals can contact Allergan at 1-800-678-1605.
For full prescribing information and safety warnings, please refer to the respective product information materials.
About Allergan Aesthetics: Allergan Aesthetics, a division of AbbVie, is dedicated to developing, manufacturing, and marketing a range of leading aesthetics brands and products, including facial injectables, body contouring solutions, skincare products, and more. Their mission is to provide innovation, education, exceptional service, and a commitment to excellence to their customers.
About AbbVie: AbbVie is focused on discovering and delivering innovative medicines and solutions to address serious health issues today and in the future. With a portfolio spanning immunology, oncology, neuroscience, and eye care, AbbVie aims to make a significant impact on people’s lives globally.
